Author： Karlsson Hasse
Publisher： Informa Healthcare
ISSN： 0803-9488
Source： Nordic Journal of Psychiatry, Vol.64, Iss.4, 2010-08, pp. : 226-226
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Ketamine for depression: evidence, challenges and promise
World Psychiatry, Vol. 14, Iss. 3, 2015-10 ,pp. :
Ketamine for depression: evidence, challenges and promise
World Psychiatry, Vol. 1723-8617, Iss. 3, 2015-10 ,pp. :
Fluvoxamine in the treatment of severe depression
By Zohar Joseph
Primary Care Psychiatry, Vol. 9, Iss. 4, 2004-12 ,pp. :
Treatment of cytokine-induced depression
By Capuron L. Hauser P. Hinze-Selch D. Miller A.H. Neveu P.J.
Brain, Behavior, and Immunity, Vol. 16, Iss. 5, 2002-10 ,pp. :